Sheraz Ali1, Gregory M Peterson2,3, Luke R Bereznicki2, Mohammed S Salahudeen4. 1. King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia. 2. Discipline of Pharmacy, School of Medicine, University of Tasmania, Hobart, 7005, Australia. 3. Faculty of Health, University of Canberra, Canberra, ACT, Australia. 4. Discipline of Pharmacy, School of Medicine, University of Tasmania, Hobart, 7005, Australia. mohammed.salahudeen@utas.edu.au.
Abstract
PURPOSE: The purpose of the study is to conduct a systematic review of studies examining the association between anticholinergic burden and mortality in older individuals. METHODS: A literature search was performed to identify relevant studies, using MEDLINE, EMBASE, PsycINFO and CENTRAL, from January 1990 to December 2018. We included studies of patients with a mean age of 65 years or older where the anticholinergic burden was estimated using anticholinergic risk assessment tools, and associations between anticholinergic load and mortality were investigated. The primary outcome of interest was the association between anticholinergic burden and mortality. RESULTS: Twenty-seven studies were included. These were three cross-sectional, one nested case-control and 23 prospective or retrospective cohort studies. Most studies were determined to be of good quality. A total of 15 studies reported a positive correlation between anticholinergic burden and mortality, while the remaining 10 studies did not report a significant association. Eighteen out of 27 studies (80%) had a short follow-up period of 1 year or less. Among the five high-quality studies that met all the domains of the quality assessment criteria, four showed a positive association. CONCLUSION: The variation in results could relate to the quality of the studies, follow-up period, anticholinergic risk assessment tool used and the study setting. Sixty-three percent (n = 17) of all the included studies, but almost all of the high-quality studies with an extended follow-up, reported a positive correlation between anticholinergic burden and mortality. Further high-quality research, using standardized measures and with adequate follow-up periods, is required to confirm the relationship between anticholinergic burden and mortality.
PURPOSE: The purpose of the study is to conduct a systematic review of studies examining the association between anticholinergic burden and mortality in older individuals. METHODS: A literature search was performed to identify relevant studies, using MEDLINE, EMBASE, PsycINFO and CENTRAL, from January 1990 to December 2018. We included studies of patients with a mean age of 65 years or older where the anticholinergic burden was estimated using anticholinergic risk assessment tools, and associations between anticholinergic load and mortality were investigated. The primary outcome of interest was the association between anticholinergic burden and mortality. RESULTS: Twenty-seven studies were included. These were three cross-sectional, one nested case-control and 23 prospective or retrospective cohort studies. Most studies were determined to be of good quality. A total of 15 studies reported a positive correlation between anticholinergic burden and mortality, while the remaining 10 studies did not report a significant association. Eighteen out of 27 studies (80%) had a short follow-up period of 1 year or less. Among the five high-quality studies that met all the domains of the quality assessment criteria, four showed a positive association. CONCLUSION: The variation in results could relate to the quality of the studies, follow-up period, anticholinergic risk assessment tool used and the study setting. Sixty-three percent (n = 17) of all the included studies, but almost all of the high-quality studies with an extended follow-up, reported a positive correlation between anticholinergic burden and mortality. Further high-quality research, using standardized measures and with adequate follow-up periods, is required to confirm the relationship between anticholinergic burden and mortality.
Entities:
Keywords:
Anticholinergic; Anticholinergic burden; Mortality; Older people
Authors: Nicholas M Wilson; Sarah N Hilmer; Lyn M March; Jian Sheng Chen; Danijela Gnjidic; Rebecca S Mason; Ian D Cameron; Philip N Sambrook Journal: Drugs Aging Date: 2012-02-01 Impact factor: 3.923
Authors: Edwin C K Tan; Maria Eriksdotter; Sara Garcia-Ptacek; Johan Fastbom; Kristina Johnell Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Phyo Kyaw Myint; Chris Fox; Chun Shing Kwok; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw Journal: Age Ageing Date: 2014-11-27 Impact factor: 10.668
Authors: Noll Campbell; Malaz Boustani; Tony Limbil; Carol Ott; Chris Fox; Ian Maidment; Cathy C Schubert; Stephanie Munger; Donna Fick; David Miller; Rajesh Gulati Journal: Clin Interv Aging Date: 2009-06-09 Impact factor: 4.458
Authors: Caroline Krüger; Ingmar Schäfer; Hendrik van den Bussche; Horst Bickel; Angela Fuchs; Jochen Gensichen; Hans-Helmut König; Wolfgang Maier; Karola Mergenthal; Steffi G Riedel-Heller; Gerhard Schön; Siegfried Weyerer; Birgitt Wiese; Wolfgang von Renteln-Kruse; Claudia Langebrake; Martin Scherer Journal: BMJ Open Date: 2021-03-23 Impact factor: 2.692
Authors: Mohammed S Salahudeen; Adel Alfahmi; Anam Farooq; Mehnaz Akhtar; Sana Ajaz; Saud Alotaibi; Manal Faiz; Sheraz Ali Journal: J Clin Med Date: 2022-01-28 Impact factor: 4.241
Authors: Ibrahim Haider; Sam Kosari; Mark Naunton; Theo Niyonsenga; Gregory M Peterson; Jane Koerner; Rachel Davey Journal: J Clin Med Date: 2022-09-01 Impact factor: 4.964
Authors: Sam Kosari; Jane Koerner; Mark Naunton; Gregory M Peterson; Ibrahim Haider; Emily Lancsar; David Wright; Theo Niyonsenga; Rachel Davey Journal: Trials Date: 2021-06-11 Impact factor: 2.279